MD Anderson Cancer Center

@MDAndersonNews

MD Anderson is a global leader in cancer care, research, education and training, and prevention. Our mission: #EndCancer. Appointments available: 1-877-632-6789

Houston, TX

Joined February 2008

4KFollowing

142KFollowers

Pinned

MD Anderson Cancer Center@MDAndersonNews · Jul 15

Artificial intelligence can be a handy tool when you need quick answers, but there are challenges when it comes to finding accurate medical information. Our experts break down how to navigate this in the ever-expanding world of AI: spr.ly/60164fIei #EndCancer

MDAndersonNews's tweet card. Artificial intelligence can be a quick way to filter large amounts of information. But is it a reliable source for health topics? MD Anderson’s Caroline Chung, M.D., and Shawn Stapleton, Ph.D., share...

9.0K

Pinned

MD Anderson Cancer Center Retweeted

O'Neak Henigan@Luvelyo · Jul 17

🚭 Teamwork makes the (smoke-free) dream work! 💥 @HCPrecinct4, Steve Radack Community Center & @MDAndersonNews joined forces to help protect our kids from the dangers of smoking and vaping! Healthy habits, happier futures! 🙌 #EndCancer

2.0K

Pinned

MD Anderson Cancer Center@MDAndersonNews · Jul 16

The William O. Russell Annual Conference offers a deep dive into the latest classification systems in tumor pathology, challenging diagnostic issues, and new molecular tests shaping diagnosis and prognosis. Professionals will gain practical tools and strategies they can apply…

2.0K

MD Anderson Cancer Center@MDAndersonNews · 19 h

Using data from 2,300 metastatic lung cancer cases, a machine learning model demonstrated the potential to improve treatment decisions beyond single biomarker approaches. Learn more: spr.ly/6011fzq1D #EndCancer

MDAndersonNews's tweet card. A team led by Jia Wu, Ph.D., used over 2,300 cases from four different cancer centers to develop a machine learning model called A-STEP (Attention-based Scoring for Treatment Effect Prediction) that...

1.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 19

A virtual live-streaming course will offer comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be…

MDAndersonNews's tweet image. A virtual live-streaming course will offer comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be…

2.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 18

There's more to advance care planning for end of life than just filling out legal forms. In this Cancerwise podcast, our experts break down the important conversations patients and caregivers should also consider having throughout the process: spr.ly/6016fBFJG #EndCancer

MDAndersonNews's tweet image. There's more to advance care planning for end of life than just filling out legal forms.

In this Cancerwise podcast, our experts break down the important conversations patients and caregivers should also consider having throughout the process: spr.ly/6016fBFJG #EndCancer

4.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 17

Recent MD Anderson research suggests inhibiting alanine transporter proteins, including SLC38A2, led to reduced alanine, slowed cell growth and tumor shrinkage. Learn more: spr.ly/60164htt0 #EndCancer

MDAndersonNews's tweet card. Study uncovers target to overcome resistance in ARID1A-mutant cancers

2.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 16

MD Anderson researchers combined immunotherapy with a non-toxic bacteria species that can trigger an antitumor response. Read how patients with treatment-refractory solid tumors responded: spr.ly/601847IK6 #EndCancer

$MDAndersonNews's tweet card. Combining immunotherapy with bacterial injection shows promise in treatment-refractory solid tumors$

2.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 14

Congratulations to this year's American Society for Radiation Oncology fellows! Four MD Anderson physicians were selected for their contributions to cancer research, education, patient care and the specialty of radiation oncology. Learn more about them: spr.ly/601744MjW…

MDAndersonNews's tweet card. The American Society for Radiation Oncology selected 43 members to receive the ASTRO Fellow designation this year. Fellows are chosen for their achievements and contributions to ASTRO, cancer...

3.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 14

Chief digital officers are leading the charge in implementing tools that modernize healthcare delivery. Read why @BeckersHR recognizes MD Anderson's Chief Technology and Digital Officer as a leader in this space: spr.ly/601444Jkw #EndCancer

MDAndersonNews's tweet card. Becker’s is proud to recognize 50 chief digital officers who are driving digital transformation in hospitals and health systems nationwide in 2025. As digital efforts become a top priority in...

3.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 13

Rezatapopt can restore function to mutant p53 in acute myeloid leukemia. Combining it with venetoclax or other inhibitors boosts its anti-leukemia effects. Learn more: spr.ly/60164L3Bm #Leukemia #EndCancer

MDAndersonNews's tweet card. Novel agent partially restores p53 function in p53-mutated AML

4.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 11

New research shows that specific co-mutations in KRAS-mutant non-small cell lung cancer may predict better response to ATR inhibitors. Read more: spr.ly/60144IbWM #LungCancer #EndCancer

MDAndersonNews's tweet card. Specific co-mutations in KRAS-mutant NSCLC improve treatment response

2.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 11

Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research. We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll #EndCancer

MDAndersonNews's tweet image. Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research.

We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll
#EndCancer

15.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 10

Patients with advanced melanoma who received nivolumab + relatlimab before and after surgery had lasting results four years later. Biomarkers may help predict who benefits most. spr.ly/60104xK7i #EndCancer

MDAndersonNews's tweet card. Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87% of patients with stage III melanoma remained alive, according to new...

5.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 9

Recent research showed a correlation between new-onset diabetes and pancreatic cancer, suggesting it could be a potential marker for earlier detection. Learn more: spr.ly/60194Qzoz

MDAndersonNews's tweet card. New-onset diabetes may serve as an early marker of pancreatic cancer

3.0K

MD Anderson Cancer Center Retweeted

Peter WT Pisters, MD@ppisters · Jul 4

Happy Independence Day to our @MDAndersonNews community. I extend my deep gratitude to our veteran teammates for their admirable service, as well as to our colleagues who are caring for our patients today and during the holiday weekend. #EndCancer

3.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 3

Recent research from MD Anderson provide epigenetic insights into blood disorders involving low platelets. Learn more: spr.ly/60134lftF #EndCancer

MDAndersonNews's tweet card. Study provides epigenetic targets for conditions with low platelet counts

2.0K

MD Anderson Cancer Center@MDAndersonNews · Jul 2

Patients with ovarian clear cell carcinoma whose tumors have specific gene mutations gene were found to have improved survival following immunotherapy. Read what our researchers found about this genetic marker: spr.ly/60114l1gt #EndCancer

MDAndersonNews's tweet card. New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers

3.0K

MD Anderson Cancer Center Retweeted

Nature Cancer@NatureCancer · Jun 30

📢We’ve partnered with MD Anderson to explore recent breakthroughs in understanding the tumor ecosystem and how its various components influence cancer development, progression, diagnosis, and treatment. Learn more and save your seat! 🔗go.nature.com/44cJT9Z

8.0K